Collaboration and licensing agreement for PNT2003Collaboration and Licensing Agreement • August 25th, 2023 • Delaware
Contract Type FiledAugust 25th, 2023 JurisdictionLantheus Holdings and POINT Biopharma Global announced a set of strategic collaboration agreements in which Lantheus will license exclusive worldwide rights to POINT’s PNT2002 and PNT2003 product candidates.